Skip to main content
. 2022 Jun 21;13(9):2781–2797. doi: 10.7150/jca.73690

Figure 8.

Figure 8

Clinicopathological features of miR-21 and ARHGAP24 in patients with PDAC. (A) Representative images of ISH of miR-21 in TMA samples of AJCC 0-IIA vs IIB-IV stage (scale bar, 100 um; magnification, x200). (B) Representative images of IHC of ARHGAP24 in TMA samples of AJCC 0-IIA vs IIB-IV stage (scale bar: 100 um, magnification: 200x). (C) IHC staining of the TMA determined the overall survival of patients with low and high ARHGAP24 expression levels. (D) Overall survival probability in 177 patients with PDAC with low (n=84) and high (n=93) ARHGAP24 expression levels were determined using a Kaplan-Meier plotter and log-rank test. (E) Kaplan-Meier curves for relapse free survival in 69 patients with PDAC with low (n=31) and high (n=38) ARHGAP24 expression levels were produced using a Kaplan-Meier plotter, followed by the log-rank test.